Ubs Oconnor LLC Decibel Therapeutics, Inc. Transaction History

Ubs Oconnor LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$2.41 - $4.81 $480,072 - $958,151	199,200 New	199,200 $767 Million
Q1 2023 May 15, 2023	BUY	$2.08 - $4.79 $2,953 - $6,801	1,420 Added 0.76%	189,386 $571,000
Q4 2022 Feb 14, 2023	BUY	$1.86 - $3.54 $56,211 - $106,982	30,221 Added 19.16%	187,966 $0
Q3 2022 Nov 14, 2022	BUY	$3.82 - $5.61 $267,400 - $392,700	70,000 Added 79.78%	157,745 $546 Million
Q2 2022 Aug 12, 2022	BUY	$1.85 - $4.21 $162,328 - $369,406	87,745 New	87,745 $369,000

Ticker DBTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,964,500
Description
Decibel Therapeutics, Inc., a clinical-stage biotechnology company, engages in discovering and developing transformative treatments for hearing and balance disorders. Its product candidates and programs focuses on three areas, such as Gene Therapies for Congenital, Monogenic Hearing Loss designed to restore functional cells within the cochlea to...

Get notified when there are updates to the investment portfolio of Ubs Oconnor LLC, based on Form 13F filings with the SEC.

Stay updated on Ubs Oconnor LLC with notifications on news.